Research News From December 24, 2014
advertisement
- Most People With Long-Duration Type 1 Diabetes in a Large Population-Based Study Are Insulin Microsecretors. See also One in Every Three People with Type 1 Diabetes Produces Insulin Years Post-Diagnosis Largest Study to Date of Residual Insulin Production Proves Such Patients Are Not ‘Exceptional’; Major Clinical and Health Policy Implications.
- Prevalence of Detectable C-peptide According to Age at Diagnosis and Duration of Type 1 Diabetes.
- Anti-thymocyte globulin/G-CSF treatment preserves beta cell function in patients with established type 1 diabetes.
- Early Childhood Gut Microbiomes Show Strong Geographic Differences Among Subjects at High Risk for Type 1 Diabetes.
- Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years.
- A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History.
- HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk.
- Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3-6 years: comparison between diluted and standard insulin strength. Free full text available in HTML and PDF formats.
- Effects of vitamin D repletion on glycemic control and inflammatory cytokines in adolescents with type 1 diabetes.
- Circadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas.
- Residual beta-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes.
- Restoration of Glucose Counterregulation by Islet Transplantation in Long-Standing Type 1 Diabetes.
- Incidence of End Stage Renal Disease among Type 1 Diabetes: A Nationwide Cohort Study in Taiwan.
- Artificial sweeteners induce glucose intolerance by altering the gut microbiota.
